Literature DB >> 18175066

Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.

Amir Ghorbanihaghjo1, Pegah Veisi, Hassan Argani, Mohammad Aghaeishahsavari, Masood Noroozianavval, Nadereh Rashtchizadeh, Mehran Mesgari, Javid Safa, Hosain Babaei.   

Abstract

BACKGROUND: In this study the effect of losartan and enalapril on the reduction of DNA damage was evaluated in regard to renin-angiotensin system (RAS) polymorphisms.
METHODS: After determination of genotypes of RAS polymorphism by PCR, 64 renal transplant recipients were randomly allocated to one of four groups: the first and second groups were treated with E (E+: 10 mg/day) and L (L+: 50 mg/day) alone, respectively. The third group received E+L (E+L+: 10 + 50 mg/day), and the forth group received no medication (E-L-). The subjects were followed for 8 weeks. After a 2-week washout period, the E group changed to L and vice versa as a cross-over design. They were followed for another 8 weeks. Before and after treatment, we checked 8-OHdG and malondialdehyde (MDA) as biomarkers of DNA damage and lipid peroxidation, respectively.
RESULTS: 8-OHdG levels were significantly decreased after treatment in the E+L+ and L+ groups (P < 0.001, P = 0.001, respectively). Only the TT genotype of AGT had the most antioxidative role regarding the treatment (P = 0.01). We found a remarkable correlation between MDA and DNA damage levels before and after intervention (r = 0.48, P < 0.001; r = 0.35, P = 0.006).
CONCLUSION: The protective effects of L+ and E+L+ on DNA breaks are surprising regarding the RAS polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175066     DOI: 10.1007/s10157-007-0001-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  54 in total

1.  A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods.

Authors:  M B Bogdanov; M F Beal; D R McCabe; R M Griffin; W R Matson
Journal:  Free Radic Biol Med       Date:  1999-09       Impact factor: 7.376

Review 2.  Genetic responses against nitric oxide toxicity.

Authors:  B Demple
Journal:  Braz J Med Biol Res       Date:  1999-11       Impact factor: 2.590

3.  No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.

Authors:  Torsten Slowinski; Petra Diehr; Patrick Kleemann; Lutz Fritsche; Lutz Renders; Klemens Budde; Ingeborg A Hauser; Hans H Neumayer; Berthold Hocher
Journal:  Nephrol Dial Transplant       Date:  2004-09-07       Impact factor: 5.992

4.  Correlation between formamidopyrimidine DNA glycosylase (Fpg)-sensitive sites determined by a comet assay, increased MDA, and decreased glutathione during long exposure to thinner inhalation.

Authors:  M Martínez-Alfaro; L Palma-Tirado; F Sandoval-Zapata; A Cárabez-Trejo
Journal:  Toxicol Lett       Date:  2006-06-01       Impact factor: 4.372

5.  Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis.

Authors:  Abdurrahim Kocyigit; Huseyin Keles; Sahbettin Selek; Salih Guzel; Hakim Celik; Ozcan Erel
Journal:  Mutat Res       Date:  2005-08-01       Impact factor: 2.433

6.  Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens.

Authors:  Abdulgaffar Vural; Mahmut Ilker Yilmaz; Kayser Caglar; Ahmet Aydin; Alper Sonmez; Tayfun Eyileten; Cengizhan Acikel; Bulent Gulec; Orhan Kozak; Koksal Oner
Journal:  Am J Nephrol       Date:  2005-05-27       Impact factor: 3.754

Review 7.  Lipid peroxides in hepatic, gastrointestinal, and pancreatic diseases.

Authors:  K Yagi
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

8.  Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension.

Authors:  R Abdi; T B Tran; R Zee; B M Brenner; E L Milford
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

9.  Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

Authors:  Christine Krämer; Julia Sunkomat; Jana Witte; Maren Luchtefeld; Michael Walden; Boris Schmidt; Dimitrios Tsikas; Rainer H Böger; Wolf-Georg Forssmann; Helmut Drexler; Bernhard Schieffer
Journal:  Circ Res       Date:  2002-04-19       Impact factor: 17.367

10.  Generation of 8-hydroxydeoxyguanosine from DNA using rat liver homogenates.

Authors:  Minyi Shi; Haruko Takeshita; Masaharu Komatsu; Baohui Xu; Kohji Aoyama; Toru Takeuchi
Journal:  Cancer Sci       Date:  2005-01       Impact factor: 6.716

View more
  2 in total

1.  Enalapril reduces germ cell toxicity in streptozotocin-induced diabetic rat: investigation on possible mechanisms.

Authors:  S Kushwaha; G B Jena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

Review 2.  Antihypertensive treatment for kidney transplant recipients.

Authors:  Nicholas B Cross; Angela C Webster; Philip Masson; Philip J O'Connell; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.